Viyash Scientific Limited (NSE: VIYASH) reports strong Q1 FY27 results with a 19.5% YoY revenue growth and a 59.2% YoY EBITDA increase.
Viyash Scientific Limited (VIYASH) reports strong Q1 FY27 results with revenues up 19.5% and PAT surging 114.9%.
Viyash Scientific Limited (NSE: VIYASH) moves up 5% intraday to ₹269.2, extending gains in the Healthcare sector.
Viyash Scientific Limited (VIYASH) acquires Italy's BioForLife, boosting its European companion animal health market presence.
Viyash Scientific Limited (VIYASH) reports record Q4 FY26 results with EBITDA surpassing Rs. 200 Cr and PAT up by 306%.